SALE
Research Handling Note
Before opening: Allow sealed vials to reach ambient laboratory temperature first, to prevent condensation forming inside.
Storage: −20°C, protected from light and moisture.
All handling and laboratory procedures are determined by the receiving laboratory under its own protocols.
CJC-1295 With DAC 5mg
£84.99
£106.99
CJC-1295 (with DAC) is a GHRH analogue conjugated to a drug affinity complex, studied for its extended half-life and sustained stimulation of growth hormone secretion relative to the non-DAC form.
Research Applications
- Extended-duration GHRH receptor signalling research
- Sustained vs pulsatile growth hormone release studies
- Comparative pharmacokinetic research against CJC-1295 without DAC
Compound Information
Modified GHRH(1-29) analogue conjugated to a maleimidopropionic acid drug affinity complex. Supplied as lyophilised powder.
Technical Specifications
- Molecular Formula: C165H271N47O46
- Molecular Weight: 3647.15 g/mol
- Sequence: Modified GHRH(1-29) conjugated to a maleimidopropionic acid drug affinity complex
- CAS Number: 863288-34-0
For laboratory research use only. Not for human or veterinary use. Not a drug, food, cosmetic, or dietary supplement, and not evaluated by the MHRA or any regulatory body for safety or efficacy. Buyers are responsible for ensuring their use complies with applicable laws and regulations.
Why Buy From Us
✓ Full batch documentation - CoA and SDS on every order
✓ Stored in a monitored, temperature-controlled facility
✓ UK dispatch, research-use documentation included
